Literature DB >> 17540345

Irreversible binding of a novel phenylisothiocyanate tropane analog to monoamine transporters in rat brain.

Vishakantha Murthy1, Huw M L Davies, Simon J Hedley, Steven R Childers.   

Abstract

Irreversible tropane analogs have been useful in identifying binding sites of cocaine on biogenic amine transporters, including transporters for dopamine (DAT), serotonin (SERT) and norepinephrine (NET). The present study characterizes the properties of the novel phenylisothiocyanate tropane HD-205, synthesized from the highly potent 2-napthyl tropane analog WF-23. In radioligand binding studies in brain membranes, direct IC(50) values of HD-205 were 4.1, 14 and 280nM at DAT, SERT and NET, respectively. Wash-resistant binding was characterized by preincubation of HD-205 with brain membranes, followed by extensive washing before performing transporter radioligand binding. Results for HD-205 showed wash-resistant IC(50) values of 191, 230 and 840nM at DAT, SERT and NET, respectively. Saturation binding studies with [(125)I]RTI-55 in membranes pretreated with 100nM HD-205 showed that HD-205 significantly decreased the B(max) but not K(D) of DAT and SERT binding. To further characterize its irreversible binding, an iodinated analog of HD-205, HD-244, was prepared from a trimethylsilyl precursor. The direct IC(50) of HD-244 at DAT was 20nM. [(125)I]HD-244 was synthesized with chloramine-T, purified on HPLC, reacted with rat striatal membranes, and proteins were separated by SDS-PAGE. Results showed several non-specific labeled bands, but only a single specific band of radioactivity co-migrating with an immunoreactive DAT band at approx. 80 kilodaltons was detected, suggesting that [(125)I]HD-244 covalently labeled DAT protein in striatal membranes. These results demonstrate that phenylisothiocyanate analogs of WF-23 can be used as potential ligands to map distinct binding sites of cocaine analogs at DAT.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17540345      PMCID: PMC4701044          DOI: 10.1016/j.bcp.2007.04.019

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  40 in total

1.  Dopamine transporter tryptophan mutants highlight candidate dopamine- and cocaine-selective domains.

Authors:  Z Lin; W Wang; G R Uhl
Journal:  Mol Pharmacol       Date:  2000-12       Impact factor: 4.436

2.  Cocaine receptors on dopamine transporters are related to self-administration of cocaine.

Authors:  M C Ritz; R J Lamb; S R Goldberg; M J Kuhar
Journal:  Science       Date:  1987-09-04       Impact factor: 47.728

3.  Dopamine transporter proline mutations influence dopamine uptake, cocaine analog recognition, and expression.

Authors:  Z Lin; M Itokawa; G R Uhl
Journal:  FASEB J       Date:  2000-04       Impact factor: 5.191

4.  Tyrosine-533 of rat dopamine transporter: involvement in interactions with 1-methyl-4-phenylpyridinium and cocaine.

Authors:  C Mitsuhata; S Kitayama; K Morita; D Vandenbergh; G R Uhl; T Dohi
Journal:  Brain Res Mol Brain Res       Date:  1998-05

5.  Pharmacological profile of radioligand binding to the norepinephrine transporter: instances of poor indication of functional activity.

Authors:  Maarten E A Reith; Lijuan C Wang; Aloke K Dutta
Journal:  J Neurosci Methods       Date:  2005-04-15       Impact factor: 2.390

6.  Selective labeling of serotonin uptake sites in rat brain by [3H]citalopram contrasted to labeling of multiple sites by [3H]imipramine.

Authors:  R J D'Amato; B L Largent; A M Snowman; S H Snyder
Journal:  J Pharmacol Exp Ther       Date:  1987-07       Impact factor: 4.030

7.  Novel 2-substituted cocaine analogs: uptake and ligand binding studies at dopamine, serotonin and norepinephrine transport sites in the rat brain.

Authors:  B A Bennett; C H Wichems; C K Hollingsworth; H M Davies; C Thornley; T Sexton; S R Childers
Journal:  J Pharmacol Exp Ther       Date:  1995-03       Impact factor: 4.030

8.  Novel 2-substituted cocaine analogs: binding properties at dopamine transport sites in rat striatum.

Authors:  H M Davies; E Saikali; T Sexton; S R Childers
Journal:  Eur J Pharmacol       Date:  1993-01-04       Impact factor: 4.432

9.  High-affinity binding of [125I]RTI-55 to dopamine and serotonin transporters in rat brain.

Authors:  J W Boja; W M Mitchell; A Patel; T A Kopajtic; F I Carroll; A H Lewin; P Abraham; M J Kuhar
Journal:  Synapse       Date:  1992-09       Impact factor: 2.562

10.  Differential binding of tropane-based photoaffinity ligands on the dopamine transporter.

Authors:  R A Vaughan; G E Agoston; J R Lever; A H Newman
Journal:  J Neurosci       Date:  1999-01-15       Impact factor: 6.167

View more
  2 in total

1.  Azido-iodo-N-benzyl derivatives of threo-methylphenidate (Ritalin, Concerta): Rational design, synthesis, pharmacological evaluation, and dopamine transporter photoaffinity labeling.

Authors:  David J Lapinsky; Ranganadh Velagaleti; Nageswari Yarravarapu; Yi Liu; Yurong Huang; Christopher K Surratt; John R Lever; James D Foster; Rejwi Acharya; Roxanne A Vaughan; Howard M Deutsch
Journal:  Bioorg Med Chem       Date:  2010-11-04       Impact factor: 3.641

2.  A novel photoaffinity ligand for the dopamine transporter based on pyrovalerone.

Authors:  David J Lapinsky; Shaili Aggarwal; Yurong Huang; Christopher K Surratt; John R Lever; James D Foster; Roxanne A Vaughan
Journal:  Bioorg Med Chem       Date:  2009-05-03       Impact factor: 3.641

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.